Humira patent thicketing strategy not anticompetitive, court rules
Antitrust doctrine not “proper fix” for any problems at the USPTO or FDA, says Illinois judge
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.